NCT03755804 2026-02-23
Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
Clinical Trials
15 trialsNCT05427136 2025-03-26
SWISS-Pearl
University Children's Hospital Basel
Recruiting
NCT06662929 2024-10-29
PROMs
King Saud University
Recruiting
NCT02714530 2021-03-30
ThoRaT
Oslo University Hospital
Phase 2 Terminated
NCT02500173 2021-03-09
Analysis of Effects and Side Effects in Patients Undergoing Radiation Therapy
Kantonsspital Graubuenden
Terminated
NCT02403531 2020-06-02
Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer
Sun Yat-sen University
Phase 2 Completed
NCT03677531 2020-05-04
Video Distraction to Decrease Use of Sedation in Pediatric Participants During Radiation Therapy
OHSU Knight Cancer Institute
Phase 1 Completed
NCT01272622 2019-11-06
Prospective Study of Children and Adolescents With Craniopharyngioma
Klinikum Oldenburg gGmbH
Phase NA Completed
NCT01518621 2019-03-13
RadEr
Oslo University Hospital
Phase 2 Terminated
NCT02962804 2018-03-05
Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)
University of Kansas Medical Center
Phase 2 Withdrawn
NCT00682786 2017-10-06
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
Washington University School of Medicine
Phase 2 Completed
NCT01642732 2017-05-30
Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 1 Terminated
NCT00400114 2017-05-08
Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer
University Health Network, Toronto
Phase 2 Completed
NCT01734564 2017-04-11
Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors
Clinica Universidad de Navarra, Universidad de Navarra
Phase 2 Completed
NCT00660699 2015-05-27
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers
Washington University School of Medicine
Phase 2 Completed